"Designing Growth Strategies is in our DNA"
The global resuscitation devices market size was valued at USD 4.78 billion in 2023. The market is projected to grow from USD 5.06 billion in 2024 to USD 9.00 billion by 2032, exhibiting a CAGR of 7.5% during the forecast period.
Resuscitation devices such as automated external defibrillators and manual resuscitators, are used to ventilate the lungs to initiate the breathing of an unconscious person. The increasing prevalence of obstructive pulmonary disease and cardiovascular diseases and the increasing number of road accidents have been fueling the demand for these devices globally.
Furthermore, the increasing focus of market players on new product launches and rising awareness among the population regarding the above-mentioned emergency cases has also been fueling the global resuscitation devices market growth.
The global resuscitation devices market experienced a decline during the COVID-19 outbreak in 2020 due to the reduced number of accidents, emergency cases requiring resuscitation, and hospital admissions. However, the market experienced significant growth in 2021 and 2022 due to the increase in the number of hospital visits.
Increasing Focus of Market Players on New Product Launches
The prevalence of cardiovascular diseases, and pulmonary diseases has been increasing significantly. Moreover, the cases of respiratory diseases in newborns and emergency medical cases requiring resuscitation devices have been increasing significantly worldwide.
Such an increasing burden of cardiac arrest and respiratory problems has been increasing the demand for these devices globally. In order to fuel this increasing demand, market players have increased their focus on new product launches.
Moreover, market players have also been focusing on expanding their product availability across the globe. For instance, in August 2023, Medline, a medical device manufacturer and distributor, partnered with Flight Medical, an Israeli-based medical device company, to distribute the Flight 60 ventilator through Medline.
Request a Free sample to learn more about this report.
Increasing Prevalence of Diseases such as Pulmonary Diseases and Cardiac Arrest has been Fueling the Market Growth
The prevalence of cardiovascular diseases, chronic obstructive pulmonary disease (COPD), cardiac arrest, and other pulmonary diseases is increasing at a significant rate across the globe.
Similarly, the prevalence of chronic obstructive pulmonary disease (COPD) has also been increasing at a significant rate worldwide. For instance, as per the data published by BioMed Central Ltd in 2022, the prevalence of COPD was 8.9% among the general population aged 35 and older in Latin America and the Caribbean. As per the same research study, the prevalence of COPD among men was 13.7%, whereas in women it was 6.7%.
Such a rising burden of these diseases has been increasing the demand for emergency care and hospital admissions. For instance, as per the report published by the Centers for Disease Control and Prevention (CDC) in 2021, there were around 139.8 million total emergency department visits in the U.S. Out of this number, around 75.6 million individuals were female, and 64.2 million were male.
The prevalence of the above-mentioned chronic diseases and the increasing number of emergency care visits have been increasing the demand for resuscitation devices for emergency treatment and providing critical care in ambulances.
Furthermore, the increasing proportion of premature births has also fueled the demand for these devices. For instance, as per the data published by the World Health Organization (WHO), in 2020, there were around 13.4 million preterm births globally. This number ranged between 4.0 and 16.0% in 2020 across countries.
The rising prevalence of chronic obstructive pulmonary disease (COPD), cardiac arrest, and the high incidence of preterm births has been fueling the demand for resuscitation devices, thereby fueling the market growth.
Complications Associated with the Use of Airway Management Devices have been Negatively Impacting the Market
The increasing prevalence of respiratory disorders and cardiac arrest has been fueling the demand for resuscitation devices. However, certain limitations are associated with using airway management devices, which have been hampering the market growth.
Moreover, other airway management devices, such as laryngeal masks, can also cause certain complications in pediatric patients, including airway restriction, vomiting, stridor, and soft tissue trauma.
Such complications associated with the use of these airway management devices have been limiting their adoption among the population, thereby hindering market growth.
Airway Management Devices Dominated due to Increasing Prevalence of COPD
On the basis of product, the market is segmented into airway management devices, emergency care ventilators, and defibrillators.
The airway management devices are further sub-segmented into infraglottic devices, supraglottic devices, laryngoscopes, and others. The airway management devices segment dominated the market in 2023. The dominance of the segment is attributed to the rising prevalence of chronic obstructive pulmonary diseases (COPD) and increasing demand for these devices.
Moreover, the ventilators segment is expected to grow at a significant CAGR during the forecast period. The growth of the segment is attributed to the increasing number of emergency care visits and the increasing number of new product launches.
To know how our report can help streamline your business, Speak to Analyst
Hospitals & ASCs Segment Dominated due to High Volume of Emergency Department Visits
Based on end-user, the market is segmented into hospitals & ASCs, homecare, and others.
The hospitals & ASCs segment dominated the market in 2023. The dominance of the segment is attributed to the increasing number of emergency department visits.
Moreover, the homecare segment is expected to grow at a significant CAGR during the forecast period. The growth of the segment is attributed to the increasing cases of sudden cardiac arrest, rising geriatric population, and rising awareness regarding emergency resuscitation devices.
By geography, the market is studied across Europe, North America, the Asia Pacific, Latin America, and the Middle East & Africa.
North America Resuscitation Devices Market Size, 2023 (USD Billion)
To get more information on the regional analysis of this market, Request a Free sample
North America dominated the global market in 2023 by accounting for major market share of USD 2.44 billion. The increasing number of cases of sudden cardiac arrests in the U.S. has been creating awareness regarding these devices for the emergency first line of treatment. This factor has been fueling the market growth in the region.
The market in Europe accounted for a substantial market share in 2023, attributed to the strong presence of market players such as Koninklijke Philips N.V., Hamilton Medical, and Convatec Group PLC, among others.
The Asia Pacific market is anticipated to grow at a significant CAGR during the forecast period. The growth of the market in Asia Pacific is attributed to the rising prevalence of chronic obstructive pulmonary disease and cardiovascular diseases, which can lead to sudden cardiac arrests in the region. This factor has been fueling the demand for emergency resuscitation in the region.
Increasing Focus of Market Players on Introducing Technologically Advanced Resuscitation Devices is Responsible for their Growth in the Market
Getinge AB, Ambu A/S, and Teleflex Incorporated are the key players that accounted for a significant portion of the global resuscitation devices market share in 2023. The growth of these players in the market is attributed to their focus on the launch of technologically advanced resuscitation devices.
Moreover, other players in the market, such as Koninklijke Philips N.V., Hamilton Medical, and Getinge AB, among others, have been focusing on the expansion of their production capacity to fuel their revenue growth.
The global resuscitation devices market report provides a detailed competitive landscape. It also includes key insights, such as top industry developments covering partnerships, mergers, and acquisitions. Additionally, it focuses on key points, such as new product launches in the market. Furthermore, the report covers regional analysis of different segments, profiles of key market players, market trends, and the impact of COVID-19 on the market. The report consists of quantitative and qualitative insights that have contributed to the market's growth.
To gain extensive insights into the market, Request for Customization
ATTRIBUTE | DETAILS |
Study Period | 2019-2032 |
Base Year | 2023 |
Estimated Year | 2024 |
Forecast Period | 2024-2032 |
Historical Period | 2019-2022 |
Growth Rate | CAGR of 7.5% from 2024-2032 |
Unit | Value (USD billion) |
Segmentation | By Product
|
By End-user
| |
By Region
|
Fortune Business Insights says that the global market stood at USD 4.78 billion in 2023 and is projected to reach USD 9.00 billion by 2032.
In 2022, the market value stood at USD 2.44 billion.
The market is predicted to exhibit a CAGR of 7.5% during the forecast period of 2024-2032.
The airway management devices segment led the market by product in 2023.
The increasing prevalence of COPD and cardiovascular diseases are the key factors fueling the market growth.
Getinge AB, Ambu A/S, and Teleflex Incorporated are the top players in the market.
Related Reports
US +1 833 909 2966 ( Toll Free )